Physician profile
Brian Marcel Cable
NPI 1386743284
$11,484.78
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,832 · 2022: $1,578 · 2023: $2,902 · 2024: $4,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,118 · Food and Beverage: $1,437 · Education: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,118.13 |
| Food and Beverage | $1,436.71 |
| Education | $519.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,663.08 | 2021-2024 | Persona, Comprehensive Shoulder System, Comprehensive Vault Reconstruction System |
| Smith+Nephew, INC. | $1,537.34 | 2022 | |
| Novus Surgical Solutions LLC | $1,214.30 | 2021 | |
| Medical Device Business Services, INC. | $523.42 | 2021 | |
| Medacta USA, INC. | $374.95 | 2024 | |
| Skeletal Dynamics INC | $78.20 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $56.47 | 2022-2023 | Seglentis |
| Novus Surgical Consultants | $19.43 | 2023 | |
| Shield Therapeutics INC | $17.59 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.